Noile-Immune Biotech Inc. (4893.T)
JPY 145.0
(0.69%)
JPY 145.0
(0.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -775.39 Million JPY | -629.13% |
| 2022 | -106.34 Million JPY | 86.14% |
| 2021 | -767.51 Million JPY | -26.97% |
| 2020 | -604.47 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -339.28 Million JPY | -21.38% |
| 2024 Q2 | -342.53 Million JPY | -0.96% |
| 2023 Q4 | -279.53 Million JPY | -1847.02% |
| 2023 Q3 | -14.35 Million JPY | 93.23% |
| 2023 FY | -775.39 Million JPY | -629.13% |
| 2023 Q1 | -269.55 Million JPY | -202.18% |
| 2023 Q2 | -211.94 Million JPY | 21.37% |
| 2022 Q4 | 263.81 Million JPY | 0.0% |
| 2022 FY | -106.34 Million JPY | 86.14% |
| 2021 FY | -767.51 Million JPY | -26.97% |
| 2020 FY | -604.47 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 229.92% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -56.056% |
| GNI Group Ltd. | 13.1 Billion JPY | 105.915% |
| Linical Co., Ltd. | 725.72 Million JPY | 206.844% |
| Trans Genic Inc. | 89.43 Million JPY | 966.979% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 45.623% |
| Soiken Holdings Inc. | -610 Million JPY | -27.112% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -0.343% |
| AnGes, Inc. | -11.96 Billion JPY | 93.521% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 30.818% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 91.86% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 843.431% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 10.299% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 30.581% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 38.559% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 2.901% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -129.837% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 35.661% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 41.944% |
| PeptiDream Inc. | 6.77 Billion JPY | 111.448% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 59.824% |
| Ribomic Inc. | -1.11 Billion JPY | 30.533% |
| SanBio Company Limited | -4.53 Billion JPY | 82.917% |
| Healios K.K. | -3.37 Billion JPY | 77.053% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 32.871% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 44.357% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 44.733% |
| StemRIM | -2.07 Billion JPY | 62.65% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 163.479% |
| FunPep Company Limited | -994 Million JPY | 21.993% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 12.756% |
| Stella Pharma Corporation | -760.3 Million JPY | -1.985% |
| TMS Co., Ltd. | -943.25 Million JPY | 17.796% |
| Cuorips Inc. | -588.48 Million JPY | -31.76% |
| K Pharma,Inc. | 366.05 Million JPY | 311.822% |
| Takara Bio Inc. | 3 Billion JPY | 125.821% |
| ReproCELL Incorporated | -409.29 Million JPY | -89.446% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 7108.867% |
| StemCell Institute Inc. | 413.75 Million JPY | 287.402% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 636.577% |
| CellSeed Inc. | -697.77 Million JPY | -11.123% |